WP
VBIV

WMS Partners’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

WMS Partners’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-333
Closed -$8K – 288
2022
Q2 		$8K Hold
333
– – ﹤0.01% 261
2022
Q1 		$17K Buy
+333
New +$16.5K ﹤0.01% 266

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WMS Partners's VBIV Position: Q3 2022 in Review

WMS Partners sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2022, closing a stake of 333 shares — an estimated $8K sold.

WMS Partners first reported a position in VBIV in Q1 2022 and held it in 2 quarters. The position peaked at $17K in Q1 2022. 127 funds tracked by Wall St. Rank hold VBIV as of Q3 2022.

  • WMS Partners reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2022 after selling out during the quarter.
  • WMS Partners sold 333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2022, an estimated $8K.
  • WMS Partners first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2022 and held it in 2 quarters.
  • WMS Partners's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $17K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2022.

Based on WMS Partners's 13F filing for Q3 2022, filed 8 Nov 2022.